Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson’s disease participants
Deborah A. Hall, Robin M. Voigt, Thaisa M. Cantu-Jungles, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 196
Probiotics, prebiotics, and postbiotics in health and disease
Jing Ji, Weilin Jin, Shuang‐Jiang Liu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 119
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 43
An Update on Prebiotics and on Their Health Effects
Antonio Bevilacqua, Daniela Campaniello, Barbara Speranza, et al.
Foods (2024) Vol. 13, Iss. 3, pp. 446-446
Open Access | Times Cited: 17
Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective
Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 1
Lewy body diseases and the gut
Timothy R. Sampson, Malú G. Tansey, Andrew B. West, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence
Xiaoyan Liu, Yi Liu, Junlin Liu, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 4, pp. 833-845
Open Access | Times Cited: 29
The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2023-2023
Open Access | Times Cited: 26
The Role of Diet in Parkinson’s Disease
Kira Tosefsky, Julie Zhu, Yolanda N. Wang, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s1, pp. S21-S34
Open Access | Times Cited: 8
Exploring the gut microbiome-Postoperative Cognitive Dysfunction connection: Mechanisms, clinical implications, and future directions
Yan Yang, Zhipeng Xu, Jianrong Guo, et al.
Brain Behavior & Immunity - Health (2024) Vol. 38, pp. 100763-100763
Open Access | Times Cited: 8
Gastrointestinal disorders in Parkinson’s disease and other Lewy body diseases
Masaaki Hirayama, Hiroshi Nishiwaki, Tomonari Hamaguchi, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review
A. Mincic, Miklós Antal, Lorena Filip, et al.
Clinical Nutrition (2024) Vol. 43, Iss. 7, pp. 1832-1849
Closed Access | Times Cited: 7
Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights
Fatemeh Taghizadeh Ghassab, Fatemeh Shamlou Mahmoudi, Reyhaneh Taheri Tinjani, et al.
Life Sciences (2024) Vol. 350, pp. 122748-122748
Closed Access | Times Cited: 7
Butyrate as a potential therapeutic agent for neurodegenerative disorders
Prapti Chakraborty, Hasinika K. A. H. Gamage, Angela S. Laird
Neurochemistry International (2024) Vol. 176, pp. 105745-105745
Closed Access | Times Cited: 6
Past, present, and future of microbiome-based therapies
Pilar Manrique, Ignacio Montero, Marta Fernandez-Gosende, et al.
Microbiome Research Reports (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 5
The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications
Elisa Menozzi, Anthony H.V. Schapira
CNS Drugs (2024) Vol. 38, Iss. 5, pp. 315-331
Open Access | Times Cited: 5
Gut Microbiota: Role in Health and Diseases
Kanchan Bhardwaj, Bhabatosh Das, Tao Zuo, et al.
IntechOpen eBooks (2025)
Closed Access
Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
Yi Zhang, Chengjun Mo, Penghui Ai, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
The epidemiological risk and prevention and interventions in Parkinson's disease: from a nutrition-based perspective
Fan Zhang, Yuxian Liu, Yun Zhu, et al.
Journal of Nutrition (2025)
Closed Access
Functionalization of wheat bread with prebiotic dietary insoluble fiber from orange-fleshed sweet potato peel and haricot bean flours
Fasika Admasu, Eskindir Getachew Fentie, Habtamu Admassu, et al.
LWT (2024) Vol. 200, pp. 116182-116182
Open Access | Times Cited: 4
Prebiotics, Probiotics and Postbiotics: The Changing Paradigm of Functional Foods
Naveen Kango, Suresh Nath
Journal of Dietary Supplements (2024) Vol. 21, Iss. 5, pp. 709-735
Closed Access | Times Cited: 4
Mediterranean Diet Adherence, Gut Microbiota and Parkinson’s Disease: A Systematic Review
Bibi Aliya Seelarbokus, Elisa Menozzi, Anthony H.V. Schapira, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2181-2181
Open Access | Times Cited: 4
The Brain–Gut–Bone Axis in Neurodegenerative Diseases: Insights, Challenges, and Future Prospects
Rong Li, Zong Miao, Yue Liu, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 4
Difference in gut microbial dysbiotic patterns between body-first and brain-first Parkinson's disease
Don Gueu Park, Woorim Kang, In-Ja Shin, et al.
Neurobiology of Disease (2024) Vol. 201, pp. 106655-106655
Open Access | Times Cited: 4
Prebiotics as an adjunct therapy for posttraumatic stress disorder: a pilot randomized controlled trial
Robin M. Voigt, Phillip A. Engen, Michelle Villanueva, et al.
Frontiers in Neuroscience (2025) Vol. 18
Open Access
Page 1 - Next Page

Scroll to top